The PharmaLex Group, a leading specialist provider of development consulting, regulatory affairs, quality management and compliance services, as well as pharmacovigilance, is pleased to announce that the International Society for Pharmacoepidemiology (ISPE) honoured Judith K. Jones, MD, PhD, founder of The Degge Group, Ltd, a PharmaLex company, at a special event on 29 August 2017, during the 33rd ICPE.
ISPE honours individuals with special accomplishments in the field of pharmacoepidemiology.
This award is only given in exceptional circumstances, with only two Honorary Lifetime Fellowships having been bestowed to date.
Dr Jones joins an elite group, receiving her award for her lifetime productivity in the field and for her pioneering role in the Society.
She has been a member of ICPE since its inception 33 years ago. During this time, she has led ISPE as a Fellow, past President, former member of Board of Directors, Vice President Finance, keynote speaker, member of Special Interest Groups, workshop teacher, session chair, coauthor for ISPE-sponsored publications, and coined the modern term “medical products epidemiology.”
“It is a great honour to receive such as prestigious award from ISPE,” said Dr Jones, founder of The Degge Group, Ltd.
“I have spent many years working in the field of pharmacoepidemiology, so to be honoured by such a significant organisation is truly humbling,” she added.
Dr Thomas Dobmeyer, CEO, PharmaLex, explained: “We are delighted for Judith. This award is testament to her significant contribution to pharmacoepidemiology.”
“Judith has undertaken pioneering work. Passing her knowledge and insights on to her team of subject matter experts makes her expertise accessible to the entire pharmaceutical industry,” Dr Tilo Netzer, CEO PharmaLex continued.
The PharmaLex Group now has more than 650 employees, with 25 offices in 14 countries and more than 600 satisfied clients worldwide.
